The latest price target for Avanos Medical (NYSE:AVNS) was reported by JMP Securities on May 7, 2024. The analyst firm set a price target for $0.00 expecting AVNS to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for Avanos Medical (NYSE:AVNS) was provided by JMP Securities, and Avanos Medical reiterated their market perform rating.

There is no last upgrade for Avanos Medical

The last downgrade for Avanos Medical Inc happened on July 25, 2023 when Keybanc changed their price target from N/A to N/A for Avanos Medical Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Avanos Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Avanos Medical was filed on May 7, 2024 so you should expect the next rating to be made available sometime around May 7, 2025.

While ratings are subjective and will change, the latest Avanos Medical (AVNS) rating was a reiterated with a price target of $0.00 to $0.00. The current price Avanos Medical (AVNS) is trading at is $18.60, which is out of the analyst’s predicted range.